These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3004219)

  • 1. Ovarian carcinoma of low malignant potential: staging and treatment.
    Nation JG; Krepart GV
    Am J Obstet Gynecol; 1986 Feb; 154(2):290-3. PubMed ID: 3004219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of second-look laparotomy in treatment of epithelial ovarian cancer.
    McCusker MC; Hoffman JS; Curry SL; Koulos JP; Gondos B
    Gynecol Oncol; 1987 Sep; 28(1):83-8. PubMed ID: 3653773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
    Pisano C; Greggi S; Tambaro R; Losito S; Iodice F; Di Maio M; Ferrari E; Falanga M; Formato R; Iaffaioli VR; Pignata S
    Anticancer Res; 2005; 25(5):3501-5. PubMed ID: 16101169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential.
    Barakat RR; Benjamin I; Lewis JL; Saigo PE; Curtin JP; Hoskins WJ
    Gynecol Oncol; 1995 Dec; 59(3):390-3. PubMed ID: 8522261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian epithelial tumors of low malignant potential.
    Chien RT; Rettenmaier MA; Micha JP; DiSaia PJ
    Surg Gynecol Obstet; 1989 Aug; 169(2):143-6. PubMed ID: 2756462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and prognosis of mucinous tumors of the ovary.
    Kikkawa F; Nawa A; Kajiyama H; Shibata K; Ino K; Nomura S
    Gynecol Oncol; 2006 Oct; 103(1):171-5. PubMed ID: 16546243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of CA 125 measurement before second-look laparotomy in patients with ovarian carcinoma.
    Hørding U; Toftager-Larsen K; Lund B; Dreisler A; Daugaard S; Lundvall F; Knudsen JB; Bock JE
    Eur J Gynaecol Oncol; 1994; 15(3):217-21. PubMed ID: 7957327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
    Dizon DS; Restivo A; Lomme M; Charbonneau N; Brard L; Hughes T; Weitzen S; Legare R; Granai CO; Disilvestro P
    Am J Clin Oncol; 2008 Feb; 31(1):39-42. PubMed ID: 18376226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Place of second-look laparotomy after 18 courses of chemotherapy in epithelial ovarian cancer.
    Ngan HY; Wong LC; Ma HK
    Aust N Z J Obstet Gynaecol; 1989 Feb; 29(1):52-4. PubMed ID: 2562603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
    J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects of ovarian tumors of low malignant potential.
    Dgani R; Blickstein I; Shoham Z; Czernobilsky B; Ben-Hur H; Shani A; Katz Z; Borenstein R
    Eur J Obstet Gynecol Reprod Biol; 1990; 35(2-3):251-8. PubMed ID: 2159428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and treatment outcomes of patients with malignant transformation arising from mature cystic teratoma of the ovary: experience at a single institution.
    Oranratanaphan S; Khemapech N
    Asian Pac J Cancer Prev; 2013; 14(8):4693-7. PubMed ID: 24083728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage I ovarian carcinoma: specialty-related differences in survival and management.
    Puls LE; Carrasco R; Morrow MS; Blackhurst D
    South Med J; 1997 Nov; 90(11):1097-100. PubMed ID: 9386050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma].
    Sevelda P; Barrada M; Vavra N; Denison U; Schmidl S; Genger H; Salzer H
    Wien Klin Wochenschr; 1990 Aug; 102(15):441-3. PubMed ID: 2402929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative second-look laparotomy does not preclude recurrence in stage I ovarian carcinoma of any histological variety.
    Schneider J; Centeno MM; Montoya F; Rodriguez-Escudero FJ
    Eur J Gynaecol Oncol; 1993; 14(1):36-9. PubMed ID: 8472729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staging laparotomy in early epithelial ovarian carcinoma.
    Helewa ME; Krepart GV; Lotocki R
    Am J Obstet Gynecol; 1986 Feb; 154(2):282-6. PubMed ID: 3946515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous ovarian endometrioid adenocarcinoma and endocervical mucinous adenocarcinoma.
    Huang YD; Hung YC; Yeh LS; Chiang IP; Zeng GC; Chang WC
    Taiwan J Obstet Gynecol; 2006 Sep; 45(3):264-7. PubMed ID: 17175478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stage III and IV epithelial cancer of the ovary. Prognostic role of surgical tumor reduction].
    Le Bouedec G; Ben Ahmed S; Plagne R; Dauplat J
    Presse Med; 1990 Mar; 19(11):506-10. PubMed ID: 2138748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical staging in patients with ovarian tumors of low malignant potential.
    Winter WE; Kucera PR; Rodgers W; McBroom JW; Olsen C; Maxwell GL
    Obstet Gynecol; 2002 Oct; 100(4):671-6. PubMed ID: 12383532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of neoadjuvant chemotherapy in the management of advanced ovarian cancer.
    Zhao D; Wu LY; Wang XB; Li XG
    Asian Pac J Cancer Prev; 2015; 16(6):2369-73. PubMed ID: 25824766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.